ACAD
ACADIA Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · US
$28.04
+0.64%Leverage
- Debt / equity
- 0.06x
- Net debt / equity
- -0.24x
- Debt / assets
- 0.04x
- Debt / EBITDA
- 0.64x
- Net debt / EBITDA
- -2.68x
Liquidity & coverage
- Current ratio
- 3.39x
- Quick ratio
- 3.30x
- Cash ratio
- 2.65x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $863.1M
Cash & dividend
- FCF / debt
- 2.36x
- Cash flow / debt
- 2.63x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026